Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

Journal Article Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris Get access R. Gniadecki, R. Gniadecki Department of Dermatology, Bispebjerg University Hospital, 2200 Copenhagen N, Denmark Robert Gniadecki. E‐mail: r.gniadecki@gmail.com Search for other works by this author on: Oxford Academic Google Scholar K. Kragballe, K. Kragballe Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark Search for other works by this author on: Oxford Academic Google Scholar T.N. Dam, T.N. Dam Department of Dermatology, Roskilde Hospital, Roskilde, Denmark Search for other works by this author on: Oxford Academic Google Scholar L. Skov L. Skov Department of Dermato‐Allergology, Gentofte University Hospital, Copenhagen, Denmark Search for other works by this author on: Oxford Academic Google Scholar British Journal of Dermatology, Volume 164, Issue 5, 1 May 2011, Pages 1091–1096, https://doi.org/10.1111/j.1365-2133.2011.10213.x Published: 01 May 2011